FRI0034 Adalimumab reduces CXCR4 expression during inflammatory arthritis and in fibroblast-like synoviocytes and osteoclasts under chronic TNF exposure
Rheumatoid arthritis - etiology, pathogenesis and animal models
FRI0034 Adalimumab reduces CXCR4 expression during inflammatory arthritis and in fibroblast-like synoviocytes and osteoclasts under chronic TNF exposure